PTC Therapeutics price target cut to $75 by RBC Capital
RBC Capital cut its price target for PTC Therapeutics to $75.00 from $85.00 and maintained a Sector Perform rating, per Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.